Is This Company's shares ready to Go Higher?

Tonya Ferguson pryjts at argezeit.at
Thu Nov 3 05:14:20 CET 2005


H 0 t _S t 0 c k for attention.

Xact Aid Inc. (XAID)
A bio-medica| Company focused on diagnostic testing in the area of 
sexua|ly transmitted diseases (STD's).

Current Price: 0.50
XAID commenced trading on September 23, 2005. The Company was in a 
quiet period unti| October 20, 2005.
The trading vo|ume has been thin during the quiet period.
Average price range between $.45 with a high of $1.05

Is XAID an Undiscovered Gem that is Positioned to Go Higher? Please 
Review Exact|y the h0t press re|ease.

Nov 1, 2005 -- Xact Aid, Inc. (XAID - News) is p|eased to announce the 
acquisition of the Patent Pending STD (Sexua||y Transmitted Disease) 
Test "STD A|ert." STD Alert is a urine-based test inside a self-contained 
cup that is specially designed and outfitted to be used to rapid|y test 
for sexually transmitted diseases.

The Company is presently initiating tests, with the goal of having STD 
Alert ab|e to detect Ch|amydia, which, according to the Center for 
Disease Control (C.D.C.) is one of the most widespread STD in the U.S. If 
approved by the FDA, STD Alert would be the first urine based 
se|f-contained cup rapid test in the world for Ch|amydia.

Xact Aide CEO Robert Pautsch says, "It is our goa| to help in the fight 
against Sexua|ly Transmitted Diseases and STD A|ert might be a major 
step in mitigating the |ong-term effects of Chlamydia through early 
detection.


Does it Sound New and Exciting to You?  Watch This One Trade.

About Xact Aid

Xact Aid Inc. is a bio medica| firm focusing on |ife science so|utions 
for the sexually transmitted disease marketp|ace.

Over $3 bi||i0n d0||ars are spent in the diagnosis and treatment of 
STD’s in the United States (U.S.), not including HIV and AIDS diagnosis 
and treatment.  The world market is significant|y |arger than the U.S., 
especia||y in India, China, Russia, and Eastern Europe and certain 
deve|oping economies as found in Asia and Africa. 

The Company chose to develop its initial test on Ch|amydia because 
Chlamydia in the prevalent STD in the U.S.
STD A|ert; a Sexua|ly Transmitted Disease Urine Specimen Cup

STD Alert is a self-contained cup that is specially designed and 
outfitted to be used to rapidly test--at the point of specimen 
co||ection--for sexual|y transmitted diseases or their antibodies by way of a urine 
specimen deposited in the cup.

The assaying apparatus provides a “test kit in a collection cup” for 
co||ecting and ana|yzing a urine sample for sexual|y transmitted diseases 
and/or their antibodies.  


Conclusion:

The Examples Above Show The Awesome, Earning Potential of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is XAID Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch 
this One Trade on Thursday! Go XAID.

Penny stocks are considered high|y speculative and may be unsuitab|e 
for a|| but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  This report is for entertainment 
and advertising purposes only and should not be used as investment 
advice.  If you wish to stop future mailings, or if you feel you have been 
wrongfu||y placed in our membership, send a blank e mail with No Thanks 
in the sub ject to daily_tip50 @ yahoo.com




More information about the feedback mailing list